Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

      June 8, 2023

      Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

      June 7, 2023

      Biotechs face challenges as the industry’s annual bash returns to Boston

      June 5, 2023

      The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

      June 5, 2023

      China reaching for biotech breakthroughs in space

      June 2, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»etraScience R&D Data Cloud Selected by Leading Clinical-Stage Biotechnology Company
    Bio Technology

    etraScience R&D Data Cloud Selected by Leading Clinical-Stage Biotechnology Company

    yourbiotechBy yourbiotechMay 8, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Open, cloud-local Tetra Data Platform will interface all information sources and focuses to fit and computerize information stream

    TetraScience, the R&D Data Cloud organization, declared today that Zymeworks Inc. has chosen the Tetra Data Platform (TDP) to normalize and mechanize logical information stream. As a clinical-stage biopharmaceutical organization devoted to the improvement of cutting edge multifunctional biotherapeutics, Zymeworks’ R&D motor produces and examines a lot of logical information in its journey to upset medication plan.

    “To exploit creative information science applications including AI/ML, start with fitting R&D information in the cloud,” expressed Chad Garrett, TetraScience CRO, “We’re eager to cooperate with Zymeworks on their information cloud drive and assist them with following through on their main goal to empower patients to get back to their friends and family, infection free.”

    The underlying Zymeworks arrangement of Tetra Data Platform is underway and incorporated with key frameworks and instruments supporting basic lab work processes. Via mechanizing and normalizing the progression of information across all sources and focuses on, the Tetra R&D Data Cloud will convey quicker and more extravagant bits of knowledge for Zymeworks’ researchers. Also, Zymeworks will profit from cloud-local design with more prominent uptime, security, repetition, administration, and authentic capacities.

    ABOUT TETRASCIENCE

    TetraScience is the R&D Data Cloud organization with a mission to change life sciences R&D, speed up revelation, and improve and expand human existence. The Tetra R&D Data Cloud furnishes life sciences organizations with the adaptability, versatility, and information driven abilities to empower simple admittance to concentrated, fit, and noteworthy logical information and is effectively conveyed across big business pharma and biotech associations. As an open stage, TetraScience has assembled the biggest mix organization of lab instruments, informatics applications, CRO/CDMOs, investigation, and information science accomplices, making consistent interoperability and an advancement input circle that will drive the fate of life sciences R&D. For more data, if it’s not too much trouble, visit tetrascience.com.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleOphthalmology Companies See Global Opportunities for Next-Gen, Non-Invasive Therapies
    Next Article Investigation of DNA fix supports possibilities for quality altering innovation
    yourbiotech
    • Website

    Related Posts

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023

    The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

    June 5, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.